Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rangering i aksjer #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aksjekurs
$36.75
Sist synkronisert: 2026-08-27
Markedsverdi
$1.63B
Endring (1 dag)
-0.78%
Endring (1 år)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

EPS for Avalyn Pharma Inc. Common Stock (AVLN)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Avalyn Pharma Inc. Common Stock er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Avalyn Pharma Inc. Common Stock fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH